Pluristem Therapeutics Inc (PSTI)

[Auto1]

"For almost a thousand years, physicians have had no therapy to offer women with preeclampsia. A safe and effective therapy is needed to treat these women and prolong gestation. Pluristem's PLX cells are a unique potential therapy because they originate from the placenta, which plays a key role in preeclampsia." - Baha M. Sibai, M.D. University of Texas Medical School Feb 11, 2014 3:00 a.m. ET

Dr. Sibai, who was a moderator on the preeclampsia scientific forum, "Debate and Consensus: Preeclampsia Biomarkers in Clinical Practice, Are we ready?" at the Society for Maternal Fetal Medicine in New Orleans.

https://www.marketwatch.com/press-release/medical-key-opinion-leaders-in-preeclampsia-join-pluristems-steering-committee-2014-02-11